{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":45,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":45,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"817cea60e012","filters":{"venue":"Expert Opinion on Emerging Drugs"}},"results":[{"id":"W2127246176","doi":"10.1517/14728214.12.1.113","title":"Emerging drugs in neuropathic pain","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Queen's University","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Medicine; Neuropathic pain; Pharmacology; Chronic pain; Adverse effect; Clinical trial; Population; Intensive care medicine; Bioinformatics; Psychiatry; Internal medicine","authors":[{"name":"Ian Gilron","is_ca":true},{"name":"Terence J. Coderre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05585911933335879,"gpt":0.390085177091625,"spread":0.3342260577582662,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004166158,0.001025426,0.002362241,0.001347336,0.0001856255,0.00003833168,0.0003375606,0.0005403956,0.0002320891],"category_scores_gemma":[0.0004422615,0.0008529815,0.0008322143,0.001010239,0.00005165255,0.00009115948,0.0001256463,0.001185492,0.0003635902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005606624,"about_ca_system_score_gemma":0.0002867171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001254949,"about_ca_topic_score_gemma":0.000001691671,"domain_scores_codex":[0.9943048,0.001266525,0.001308386,0.00120903,0.000935371,0.000975856],"domain_scores_gemma":[0.9973799,0.0007554136,0.0004484402,0.0009921109,0.00006360703,0.0003605177],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003223731,0.0003714339,0.00001010097,0.002443404,0.000122858,0.0001886172,0.001500923,0.000001156283,0.000001687122,0.0003900431,0.001916414,0.9930211],"study_design_scores_gemma":[0.001038711,0.0002367482,0.000005452653,0.03436986,0.00005132276,0.00003907936,0.0004179441,0.0002214542,0.000006714862,0.00003119762,0.9629489,0.0006325747],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008497539,0.992014,0.0004281264,0.0004626495,0.002439064,0.001284333,0.000009857363,0.0002525244,0.003100985],"genre_scores_gemma":[0.00009886637,0.9948925,0.00060232,0.001562251,0.00110794,0.0002685446,0.0003650216,0.0002653459,0.0008371461],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9923885,"threshold_uncertainty_score":0.9993921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009384447","doi":"10.1517/14728214.2014.915025","title":"Emerging drugs for neuropathic pain","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Medicine; Neuropathic pain; Gabapentin; Intensive care medicine; Pharmacology; Alternative medicine","authors":[{"name":"Ian Gilron","is_ca":true},{"name":"Anthony H. Dickenson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04484334409380448,"gpt":0.3797579390529872,"spread":0.3349145949591827,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003219845,0.001046536,0.002673245,0.0005789979,0.0003758535,0.0000537681,0.0003584834,0.0004664202,0.0001350715],"category_scores_gemma":[0.0007487878,0.0008309293,0.001432861,0.0003817129,0.00004765001,0.00007025881,0.0001008326,0.0006154914,0.00026009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002861579,"about_ca_system_score_gemma":0.000248427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002708768,"about_ca_topic_score_gemma":2.411727e-7,"domain_scores_codex":[0.9950002,0.00110302,0.00109333,0.001242054,0.0007099124,0.0008515147],"domain_scores_gemma":[0.9966226,0.001180761,0.0005921425,0.001107132,0.0001165922,0.0003807812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003598431,0.0002104478,6.488801e-7,0.006053334,0.0002693463,0.00001373571,0.0006973841,0.000001005146,0.000002192893,0.001093782,0.01291435,0.9787078],"study_design_scores_gemma":[0.001225696,0.0005180831,2.79509e-7,0.02608025,0.0001622527,0.00002195277,0.0001672793,0.0008446219,0.000008851151,0.00008484306,0.9702209,0.0006649943],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[8.430687e-7,0.9846364,0.006923701,0.0009415084,0.003548261,0.002245824,0.00003237044,0.0003501126,0.001321011],"genre_scores_gemma":[0.00002980765,0.9895555,0.001677781,0.002365987,0.0024701,0.001192164,0.0008420289,0.0003559246,0.001510732],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9780428,"threshold_uncertainty_score":0.9994141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035771416","doi":"10.1517/14728214.13.1.63","title":"Emerging drugs for spinal cord injury","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Krembil Foundation; University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Neuroprotection; Clinical trial; Spinal cord injury; Neuroscience; Bioinformatics; Intensive care medicine; Pharmacology; Spinal cord; Pathology; Biology","authors":[{"name":"Darryl C. Baptiste","is_ca":true},{"name":"Michael G. Fehlings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1231186783573547,"gpt":0.4933757197572663,"spread":0.3702570413999116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007086275,0.001357804,0.003417115,0.001626247,0.0006375881,0.0000772011,0.0008878873,0.0006983881,0.0004578662],"category_scores_gemma":[0.0005188842,0.001180621,0.002028764,0.001269448,0.0002431933,0.0001955638,0.0003309351,0.00170613,0.0006834823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009250759,"about_ca_system_score_gemma":0.00121609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007424159,"about_ca_topic_score_gemma":3.2045e-7,"domain_scores_codex":[0.9928908,0.0002918338,0.001720106,0.001750241,0.001817199,0.001529841],"domain_scores_gemma":[0.996208,0.0003525866,0.0006737411,0.001655265,0.0004331682,0.0006772669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003433325,0.0002167307,9.001853e-7,0.005310735,0.0002786873,0.00002359993,0.0002008435,1.329422e-7,0.000005921546,0.0003050981,0.1160734,0.8741506],"study_design_scores_gemma":[0.001081857,0.007931536,0.000001741557,0.0296469,0.00007603401,0.0001739797,0.0003256103,0.00004731357,0.00003630968,0.00001852648,0.9596197,0.001040501],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001679202,0.9859328,0.0001958671,0.001332937,0.004476955,0.00366491,0.00008579983,0.0004159338,0.003878],"genre_scores_gemma":[0.00002406871,0.9863427,0.001662264,0.0009076608,0.005213404,0.001716995,0.0007273434,0.0004743932,0.002931143],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8731102,"threshold_uncertainty_score":0.9999173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026842455","doi":"10.1517/14728214.2012.667800","title":"Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Acute respiratory distress; Disease; Clinical trial; Psychological intervention; Lung; Internal medicine; Psychiatry","authors":[{"name":"Cory Yamashita","is_ca":true},{"name":"James F. Lewis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02716428527604438,"gpt":0.3393547807953631,"spread":0.3121904955193188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002101143,0.0007899049,0.001351035,0.0005306356,0.0002200738,0.0000324846,0.0001991232,0.0006884611,0.0001913992],"category_scores_gemma":[0.00001006459,0.0006332523,0.0005096362,0.0001590191,0.000132223,0.0001712452,0.00006399569,0.0003720181,0.00001030767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002223314,"about_ca_system_score_gemma":0.0001291271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002106235,"about_ca_topic_score_gemma":1.897236e-7,"domain_scores_codex":[0.99695,0.00009873858,0.0007698701,0.0007875445,0.0006239708,0.0007698652],"domain_scores_gemma":[0.9981933,0.000115248,0.0004842984,0.0008589065,0.0001253431,0.0002228876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001040594,0.0004584671,0.0005752927,0.0007805792,0.005064331,0.0003122496,0.0101847,3.133013e-7,0.01096885,0.0001633225,0.8894597,0.08099157],"study_design_scores_gemma":[0.002127167,0.002253656,0.0001355229,0.0006422953,0.0003171867,0.0000560153,0.00036139,0.00002166064,0.006929796,0.0000210977,0.9865543,0.0005799723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.1778358,0.1567009,0.001833034,0.6118145,0.0295362,0.01397547,0.004946623,0.001326682,0.002030815],"genre_scores_gemma":[0.07772817,0.05905961,0.005246376,0.7817708,0.0359187,0.00643436,0.01135083,0.002187958,0.02030319],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1699563,"threshold_uncertainty_score":0.9996119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236574143","doi":"10.1517/14728214.12.3.461","title":"Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"National Institutes of Health","keywords":"Medicine; ARDS; Intensive care medicine; Population; Hypoxemia; Diffuse alveolar damage; Lung; Acute respiratory distress; Internal medicine","authors":[{"name":"Karen J. Bosma","is_ca":true},{"name":"James F. Lewis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02205253104450727,"gpt":0.3533447243498627,"spread":0.3312921933053554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003003375,0.0003186962,0.0005503722,0.0003073015,0.0001764346,0.00001525508,0.00009179397,0.0001287064,0.00006538018],"category_scores_gemma":[0.00001056609,0.0002563727,0.0002086532,0.0001667049,0.00008115804,0.0001190761,0.00002978801,0.00006817994,0.00000334668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001148562,"about_ca_system_score_gemma":0.00005821644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000154536,"about_ca_topic_score_gemma":7.399984e-7,"domain_scores_codex":[0.9982609,0.00002898655,0.000506183,0.0004403815,0.0003334995,0.000430023],"domain_scores_gemma":[0.9990205,0.00007714595,0.0001882467,0.0004114174,0.00008612184,0.0002166076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006085996,0.001513261,0.008609721,0.0003361159,0.003876275,0.0002906365,0.03369609,0.000002693171,0.3318789,0.004076398,0.009340351,0.6002936],"study_design_scores_gemma":[0.006263489,0.006639295,0.005259731,0.0004932974,0.0001736569,0.00006865621,0.004095432,0.0001692808,0.2041447,0.00009774978,0.7719605,0.0006342402],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847239,0.008244327,0.002401998,0.001109829,0.001576261,0.001179851,0.0001090183,0.0001534587,0.0005013921],"genre_scores_gemma":[0.9920129,0.003510096,0.001683935,0.001121023,0.0004977134,0.0001776478,0.0001282649,0.0001014432,0.0007670239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7626202,"threshold_uncertainty_score":0.9999889,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068824007","doi":"10.1517/14728214.2013.801453","title":"Emerging anti-inflammatory drugs for atherosclerosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Inflammation; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Jeremy Berman","is_ca":false},{"name":"Michael E. Farkouh","is_ca":true},{"name":"Robert S. Rosenson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03811104574974039,"gpt":0.321154783409983,"spread":0.2830437376602427,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006257816,0.001249846,0.00283272,0.0003937481,0.0007655637,0.0001092885,0.0009349507,0.001000931,0.0009077817],"category_scores_gemma":[0.00008696427,0.001041339,0.003588287,0.0002956029,0.0002294419,0.0001946751,0.000251695,0.0006328734,0.002120468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002213279,"about_ca_system_score_gemma":0.0002168049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004096398,"about_ca_topic_score_gemma":2.107939e-7,"domain_scores_codex":[0.9953683,0.0006207186,0.001243239,0.001421615,0.000229097,0.00111701],"domain_scores_gemma":[0.9971936,0.0003873958,0.0007244698,0.001418704,0.0001475612,0.0001282069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001251191,0.0001681981,0.000003168528,0.001713164,0.001500551,2.753058e-7,0.001040429,0.000003548229,0.0002012331,0.0004247043,0.05141689,0.9435153],"study_design_scores_gemma":[0.001049921,0.00008647356,0.000009686112,0.009085018,0.0002072632,0.000005440567,0.0006965396,0.000003002561,0.0001786392,0.00001160359,0.9875183,0.001148168],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006903399,0.9898814,0.0001750158,0.0001036944,0.006492493,0.002190694,0.0001983902,0.0004150478,0.0004742169],"genre_scores_gemma":[0.0001059099,0.9931885,0.00009473445,0.0002623669,0.000918231,0.002590816,0.001180548,0.0003471931,0.001311706],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9423671,"threshold_uncertainty_score":0.9992037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019078592","doi":"10.1517/14728210802568764","title":"Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"","keywords":"Medicine; Preterm delivery; Pregnancy; Intensive care medicine; Obstetrics; Pharmacology; Gestation","authors":[{"name":"David M. Olson","is_ca":true},{"name":"Inge Christiaens","is_ca":true},{"name":"Sara Gracie","is_ca":true},{"name":"Yuka Yamamoto","is_ca":true},{"name":"B.F. Mitchell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08815268921509375,"gpt":0.3536720905677467,"spread":0.265519401352653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003070247,0.0008664157,0.00183388,0.0008622172,0.0002869894,0.00006398805,0.0002328627,0.0004243282,0.00001182055],"category_scores_gemma":[0.0003391428,0.0007993103,0.0002087387,0.0004525035,0.00009648165,0.0002169093,0.0002744997,0.0008032657,0.00001319609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000225757,"about_ca_system_score_gemma":0.0002640371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004914406,"about_ca_topic_score_gemma":0.000003143288,"domain_scores_codex":[0.9960831,0.0002450912,0.001018905,0.00129552,0.000522883,0.0008344933],"domain_scores_gemma":[0.9979263,0.0005467786,0.000357701,0.0005788896,0.00010399,0.0004863604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000444707,0.00005420015,0.00009092624,0.00499531,0.00007597441,0.0001207365,0.01071063,0.000001734997,0.000003990906,0.00002343586,0.0001901886,0.9836884],"study_design_scores_gemma":[0.001472269,0.0007532067,0.0001074419,0.1918049,0.00006004981,0.0007093343,0.001166809,0.0002985069,0.00002123792,0.00001541694,0.8024154,0.001175437],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005205587,0.9934717,0.00002195119,0.000374854,0.0005199914,0.003285774,0.00001007118,0.000189875,0.001605204],"genre_scores_gemma":[0.0009988794,0.9940791,0.002499684,0.0002187822,0.0005980713,0.00133039,0.0000434787,0.0001667147,0.00006490931],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.982513,"threshold_uncertainty_score":0.9994458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092130790","doi":"10.1517/14728214.2010.517746","title":"Emerging therapies for cystic fibrosis lung disease","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Cystic fibrosis; Mucociliary clearance; Medicine; Chloride channel; Airway; Lung; Cystic fibrosis transmembrane conductance regulator; Fibrosis; Respiratory system; Lung disease; Ion channel; Pathology; Internal medicine; Receptor; Cell biology; Anesthesia; Biology","authors":[{"name":"Hartmut Grasemann","is_ca":true},{"name":"Félix Ratjen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03499504691110344,"gpt":0.4096748499475913,"spread":0.3746798030364878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005282112,0.0009727627,0.002216793,0.0007632134,0.0004480573,0.0001195784,0.0005456067,0.000352077,0.0004177254],"category_scores_gemma":[0.001409658,0.0007586529,0.001363522,0.0005479359,0.0001987847,0.000183624,0.0001694162,0.001017346,0.0001219958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000347087,"about_ca_system_score_gemma":0.0006544638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001920545,"about_ca_topic_score_gemma":7.545345e-7,"domain_scores_codex":[0.995364,0.0001943694,0.001032231,0.001237078,0.001122708,0.001049664],"domain_scores_gemma":[0.9958069,0.001455812,0.0004344636,0.001318095,0.0002187728,0.0007659672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003174247,0.0001776497,0.000002744006,0.01468894,0.0002511217,0.000009213845,0.0005811214,0.000002638589,0.00003658132,0.0004091241,0.01985875,0.9636647],"study_design_scores_gemma":[0.0008683655,0.0002013353,0.000006021119,0.03340176,0.0001450928,0.00001252413,0.0001621872,0.0005962377,0.000009757689,0.00006685383,0.9638249,0.0007049803],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002704913,0.9901006,0.001266276,0.001504482,0.003073286,0.003190983,0.0002415488,0.0003163553,0.0003037743],"genre_scores_gemma":[0.00001776971,0.9863099,0.005452945,0.0002563493,0.002888283,0.002352606,0.00127108,0.0003261596,0.001124853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9629597,"threshold_uncertainty_score":0.9994864,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006321561","doi":"10.1517/14728210903107751","title":"Emerging drugs for major depressive disorder","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Agomelatine; Antidepressant; Monoamine neurotransmitter; Medicine; Norepinephrine; Dopamine; Serotonin; Pharmacology; Duloxetine; Melatonin; Neuroscience; Psychiatry; Receptor; Internal medicine; Psychology; Anxiety","authors":[{"name":"Sidney H. Kennedy","is_ca":true},{"name":"Sakina J. Rizvi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03552954744009842,"gpt":0.3861620325961044,"spread":0.350632485156006,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003329806,0.001458213,0.003149103,0.0008640555,0.0005244177,0.00007974754,0.0005508753,0.0007394479,0.0003037168],"category_scores_gemma":[0.0002344587,0.001129898,0.001791741,0.0005198736,0.00008401122,0.0002020122,0.0001773818,0.0007938205,0.0002525088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004941072,"about_ca_system_score_gemma":0.0003272506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005272775,"about_ca_topic_score_gemma":8.917697e-7,"domain_scores_codex":[0.994516,0.0002284822,0.001367406,0.001723712,0.001090505,0.001073871],"domain_scores_gemma":[0.9964045,0.0005505551,0.0008733035,0.001548247,0.0001673456,0.0004560393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001534829,0.0005651552,0.000004942858,0.003494438,0.0004641858,0.00001747336,0.001040337,0.000003701838,0.000002753488,0.0002031377,0.04450639,0.949544],"study_design_scores_gemma":[0.003991971,0.0004505039,0.000007516984,0.03782178,0.0003995942,0.00004191462,0.000272607,0.00005760286,0.00003263121,0.00005705036,0.9558733,0.0009935041],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000765746,0.9866803,0.0003531397,0.00206974,0.002841509,0.003964558,0.00007883453,0.0005606549,0.003443658],"genre_scores_gemma":[0.00002573755,0.9872034,0.002110218,0.0007224405,0.002507715,0.001705389,0.001813744,0.0003993623,0.003512021],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9485505,"threshold_uncertainty_score":0.9998168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026959104","doi":"10.1517/14728214.2014.882316","title":"Emerging drugs for cystic fibrosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Disease; Regulator; Genetic enhancement; Bioinformatics; Pathology; Internal medicine; Gene; Genetics; Biology","authors":[{"name":"Reshma Amin","is_ca":true},{"name":"Félix Ratjen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03955102766984114,"gpt":0.4120936363719128,"spread":0.3725426087020717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001042284,0.001205662,0.003636519,0.001051669,0.0004579351,0.0001185861,0.0007009203,0.0004915392,0.0003922854],"category_scores_gemma":[0.001705715,0.0009914611,0.001707501,0.0008088935,0.0001914412,0.0001712436,0.0002511844,0.0009221928,0.0005342285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006642382,"about_ca_system_score_gemma":0.0005414694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004751187,"about_ca_topic_score_gemma":6.631974e-7,"domain_scores_codex":[0.9935603,0.0003381619,0.00158497,0.001607655,0.001493186,0.001415757],"domain_scores_gemma":[0.9944829,0.002368626,0.0006722442,0.001537236,0.0002815609,0.0006574418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001903337,0.0001399294,3.755161e-7,0.01961372,0.000262155,0.000003950694,0.0006632243,0.00000683556,0.00001715546,0.0005659593,0.05781899,0.9207174],"study_design_scores_gemma":[0.001315677,0.0006415849,6.498478e-7,0.05084014,0.0001254534,0.00003054914,0.0002564822,0.0004835811,0.00002853819,0.00007722451,0.9453243,0.0008757839],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001054168,0.986512,0.003681622,0.001017106,0.003253269,0.003129945,0.0001314985,0.0003980554,0.001875423],"genre_scores_gemma":[0.00001538599,0.9812484,0.008875643,0.0004216715,0.003793636,0.001969826,0.001379071,0.0004122974,0.001884108],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9198416,"threshold_uncertainty_score":0.9992536,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035774269","doi":"10.1517/14728214.8.2.297","title":"Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Telithromycin; Ketolide; Streptococcus pneumoniae; Microbiology; Macrolide Antibiotics; Efflux; Erythromycin; Medicine; Antibiotics; Biology","authors":[{"name":"George G. Zhanel","is_ca":true},{"name":"Tamiko Hisanaga","is_ca":true},{"name":"Kim Nichol","is_ca":true},{"name":"Aleksandra Wierzbowski","is_ca":true},{"name":"Daryl J. Hoban","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.116053272972563,"gpt":0.4387001288850574,"spread":0.3226468559124944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005738467,0.001403417,0.00262789,0.001625892,0.001265986,0.0001312156,0.0002484063,0.0007031461,0.0001104946],"category_scores_gemma":[0.0001859764,0.001115923,0.001721666,0.0008148754,0.000121476,0.0001956122,0.00004353504,0.0007420612,0.0001443177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001856543,"about_ca_system_score_gemma":0.0009990447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004939781,"about_ca_topic_score_gemma":0.000009378893,"domain_scores_codex":[0.9946277,0.0005876794,0.001567469,0.001542624,0.0006431871,0.001031306],"domain_scores_gemma":[0.9964931,0.0004576674,0.0007365654,0.001505383,0.0002002925,0.0006070073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001020309,0.001884244,0.00001342859,0.002668954,0.0007562869,0.00004225942,0.0008858236,0.00004534359,0.0003166102,0.001055997,0.003456938,0.9887721],"study_design_scores_gemma":[0.001607066,0.00379378,0.000004300496,0.01295929,0.0002841657,0.0000712527,0.000261599,0.0000209437,0.0001152543,0.00002110561,0.9798583,0.001002995],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000217765,0.985557,0.0001177942,0.0006212972,0.005621754,0.003712559,0.0001350779,0.0006162212,0.003400543],"genre_scores_gemma":[0.0001117623,0.991459,0.00008503631,0.0018596,0.002694683,0.00238129,0.0002780209,0.0004091184,0.0007215301],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9877691,"threshold_uncertainty_score":0.9998716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091075249","doi":"10.1517/14728214.12.3.367","title":"Pharmacologic therapeutics for cardiac reperfusion injury","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; University of Lethbridge","keywords":"Medicine; Mitochondrial permeability transition pore; Cardioprotection; Reperfusion injury; Pharmacology; Bradykinin; Potassium channel; Myocardial infarction; Receptor; Ischemia; Internal medicine; Programmed cell death; Biochemistry; Chemistry; Apoptosis","authors":[{"name":"Eric R. Gross","is_ca":false},{"name":"Garrett J. Gross","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08498793500887913,"gpt":0.4486911202970438,"spread":0.3637031852881647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008759554,0.0008109306,0.002482789,0.0005048165,0.0002965885,0.00002892135,0.0002278015,0.0008990607,0.0001325825],"category_scores_gemma":[0.00006264323,0.0005800875,0.002471033,0.0004609412,0.00008574139,0.00004925332,0.0001404949,0.0008382799,0.0001011166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004362196,"about_ca_system_score_gemma":0.000366083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008714834,"about_ca_topic_score_gemma":2.427937e-8,"domain_scores_codex":[0.996558,0.0001564571,0.0009607996,0.0009787463,0.0006780713,0.0006680019],"domain_scores_gemma":[0.9979121,0.0004256127,0.0004040015,0.0008267298,0.0001783882,0.0002531635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002033698,0.0001677849,0.000001111273,0.002891517,0.0003443059,0.000005644486,0.0003721739,2.222657e-7,0.0008386612,0.00005477405,0.04203797,0.9530824],"study_design_scores_gemma":[0.000723413,0.0003781652,1.882901e-7,0.009998541,0.0003479871,0.00002386099,0.0001376505,0.00001586748,0.002738766,0.000003222064,0.9850101,0.0006222387],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005984191,0.9826638,0.00005731994,0.0004329082,0.01016384,0.00275217,0.00005801534,0.0002775037,0.003534597],"genre_scores_gemma":[0.00001465752,0.9894802,0.0004696423,0.001400529,0.005534832,0.0004700716,0.0008055361,0.0002105154,0.001614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9524602,"threshold_uncertainty_score":0.9996651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999827505","doi":"10.1517/14728214.11.2.275","title":"Emerging drugs for the treatment of chronic obstructive pulmonary disease","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; COPD; Roflumilast; Pulmonary disease; Intensive care medicine; Pharmacology; Immunology; Internal medicine","authors":[{"name":"Samir Malhotra","is_ca":true},{"name":"S. F. Paul Man","is_ca":true},{"name":"Don D. Sin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03966172483524021,"gpt":0.3782209013057312,"spread":0.338559176470491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002944566,0.001301451,0.002605492,0.0007118338,0.0005425804,0.00004486055,0.0006587816,0.0003241248,0.0003382132],"category_scores_gemma":[0.00009505522,0.0008848622,0.00262821,0.0008121128,0.0004989944,0.0001449788,0.000159469,0.0005157687,0.00006222397],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003877373,"about_ca_system_score_gemma":0.002012761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000250045,"about_ca_topic_score_gemma":0.000001809589,"domain_scores_codex":[0.9941891,0.0003022388,0.001407946,0.001563671,0.001351678,0.00118533],"domain_scores_gemma":[0.9952818,0.001147347,0.000756476,0.001937768,0.0002994522,0.0005771615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004026823,0.001475257,0.00001501355,0.01241699,0.0008048004,0.00004679228,0.0007119027,0.00004355963,0.000002071368,0.0005261886,0.003097733,0.980457],"study_design_scores_gemma":[0.001600754,0.0003919111,0.000215387,0.009539046,0.0006066132,0.00002265517,0.0006526352,0.001665749,0.0000119034,0.00008345099,0.9844849,0.0007250505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003152928,0.98791,0.00008575726,0.0009837298,0.00236822,0.00628468,0.0006993994,0.0001521359,0.001484527],"genre_scores_gemma":[0.0002725205,0.9860827,0.0001113922,0.00005584784,0.004468228,0.003697635,0.00208536,0.0003448573,0.002881471],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9813871,"threshold_uncertainty_score":0.9999737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3023787781","doi":"10.1080/14728214.2020.1763954","title":"Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dyskinesia; Pharmacology; Intensive care medicine; Internal medicine; Disease; Parkinson's disease","authors":[{"name":"Sohaila Alshimemeri","is_ca":true},{"name":"Susan H. Fox","is_ca":true},{"name":"Naomi P. Visanji","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0638396933316561,"gpt":0.3895764957156752,"spread":0.325736802384019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001927724,0.001031655,0.002522299,0.0003218448,0.0003438148,0.00004019505,0.0003776346,0.0002293832,0.0001370132],"category_scores_gemma":[0.00003929402,0.0006349644,0.001469132,0.0004680627,0.00004951806,0.0001030331,0.00005318007,0.0002174585,0.00007740426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004579468,"about_ca_system_score_gemma":0.0004063687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008688396,"about_ca_topic_score_gemma":0.000001124219,"domain_scores_codex":[0.9964582,0.0001803152,0.0009780722,0.001140138,0.0006447736,0.0005984574],"domain_scores_gemma":[0.9973465,0.0002666671,0.0006593558,0.001168701,0.0001231946,0.0004356096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000221353,0.001138232,0.000001090647,0.00136077,0.00133215,0.00003486799,0.00198046,0.000001555938,0.000008097363,0.0004943665,0.001140666,0.9922864],"study_design_scores_gemma":[0.002876706,0.001679938,0.000003316756,0.004425483,0.0008167479,0.00002036382,0.0007017689,0.0003394702,0.0001707238,0.00002316801,0.9884504,0.0004919039],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007897616,0.9921511,0.0001482627,0.001564464,0.002076641,0.00334585,0.0002041489,0.0001764226,0.0002541084],"genre_scores_gemma":[0.0007870608,0.9934274,0.0005566764,0.0003277963,0.001590899,0.001674887,0.001218236,0.0002338159,0.0001832446],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9917945,"threshold_uncertainty_score":0.9996102,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085013428","doi":"10.1517/14728214.13.2.363","title":"Emerging antidyslipidemic drugs","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Ezetimibe; Tolerability; Adverse effect; Intensive care medicine; Coronary heart disease; Niacin; Pharmacology; Statin; Internal medicine","authors":[{"name":"Rebecca L. Pollex","is_ca":true},{"name":"Tisha Joy","is_ca":true},{"name":"Robert A. Hegele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04300957262493703,"gpt":0.3725274129698519,"spread":0.3295178403449149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008137129,0.001184134,0.004215648,0.0008458673,0.0004953503,0.00003756418,0.0004601792,0.0007091744,0.0002711324],"category_scores_gemma":[0.0002159955,0.0009553529,0.003205945,0.0009457857,0.0001227039,0.0001314469,0.000185163,0.001505572,0.0006922972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005935828,"about_ca_system_score_gemma":0.0009397188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002909218,"about_ca_topic_score_gemma":4.58541e-7,"domain_scores_codex":[0.9936939,0.0004755738,0.001577861,0.001454981,0.001692278,0.001105399],"domain_scores_gemma":[0.9962808,0.0002167048,0.0006090291,0.002152594,0.0001449671,0.0005958994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002105182,0.0001408565,0.000001582402,0.004914816,0.0005518671,0.00004350754,0.001250769,0.000001446893,4.663848e-7,0.0001656332,0.04291796,0.94999],"study_design_scores_gemma":[0.0009445788,0.0001641256,0.000002504338,0.03036827,0.0001022368,0.0004493491,0.0002998394,0.00002585169,0.000005348135,0.000006311101,0.9667801,0.0008514896],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000792055,0.9839692,0.0000730006,0.0008322928,0.00475935,0.001942439,0.00001757065,0.0004694248,0.007928778],"genre_scores_gemma":[0.00001739631,0.9884592,0.0003680525,0.001335527,0.007581779,0.0004111277,0.0005188676,0.0003566191,0.0009513972],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9491385,"threshold_uncertainty_score":0.9992897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016233068","doi":"10.1517/14728214.2012.678833","title":"Emerging targets for the treatment of scleroderma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Scleroderma (fungus); Disease; Personalized medicine; Immunology; Bioinformatics; Pathology","authors":[{"name":"Andrew Leask","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1023143997969305,"gpt":0.39166777573168,"spread":0.2893533759347495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002492685,0.0005791681,0.001774191,0.0002431986,0.0002322517,0.00001515058,0.0002099154,0.0003066211,0.0001814952],"category_scores_gemma":[0.00004454433,0.000304459,0.001530401,0.0002526446,0.00007359672,0.00004327632,0.00002736755,0.0001474496,0.00005446493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002450326,"about_ca_system_score_gemma":0.0001728483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004604238,"about_ca_topic_score_gemma":1.649201e-7,"domain_scores_codex":[0.9975421,0.000120323,0.0009502031,0.0004741969,0.0004369793,0.0004761506],"domain_scores_gemma":[0.9977509,0.0005618024,0.0005713256,0.0008099995,0.00009621692,0.0002097405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000456307,0.0005516029,0.000003241815,0.002737346,0.0008940112,5.682872e-7,0.002004914,0.000002801293,0.000004182582,0.00009777529,0.008573506,0.9850844],"study_design_scores_gemma":[0.001064588,0.00030033,0.000008405978,0.02869214,0.0006116257,0.00001188438,0.0005628007,0.0000587726,0.0000317239,0.000001456162,0.9683729,0.0002833648],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004760351,0.9921586,0.00005674563,0.0004946128,0.004350822,0.002374119,0.00005857657,0.00008204937,0.0004197104],"genre_scores_gemma":[0.0001556334,0.9949531,0.00009611156,0.000123342,0.002685817,0.001041277,0.0003008345,0.0001299536,0.0005139058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9848011,"threshold_uncertainty_score":0.9999408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040792648","doi":"10.1517/14728214.13.1.81","title":"Emerging drugs for malignant glioma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Temozolomide; Radiation therapy; Oncology; Glioblastoma; Chemotherapy; Targeted therapy; Internal medicine; Cancer; Cancer research","authors":[{"name":"Warren Mason","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05204084896289074,"gpt":0.3800900213728202,"spread":0.3280491724099295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002889856,0.001221027,0.003018309,0.0010164,0.0005484011,0.00005491448,0.0003607126,0.0004956982,0.000215382],"category_scores_gemma":[0.0001344652,0.0009279198,0.002142589,0.0007163215,0.00009422723,0.00009905404,0.0001266335,0.0004884373,0.0003515467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005386767,"about_ca_system_score_gemma":0.0003560165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000808874,"about_ca_topic_score_gemma":4.824319e-7,"domain_scores_codex":[0.9952446,0.0001768284,0.001321897,0.001392907,0.0008767241,0.0009870341],"domain_scores_gemma":[0.9970387,0.0005281302,0.0006170585,0.001196645,0.000168049,0.0004514801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005828556,0.00071968,0.000002358276,0.002879295,0.0006810651,0.0001311363,0.001520861,0.000001591693,0.000004566687,0.0007566452,0.08797969,0.9052649],"study_design_scores_gemma":[0.002259115,0.0004102291,0.000001614219,0.02641588,0.000181053,0.0003365983,0.0003475811,0.00004191675,0.0001319319,0.00001815687,0.9690329,0.0008230584],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002828947,0.9898009,0.00003464738,0.001316196,0.003510384,0.002922437,0.00009490084,0.0003057,0.00198653],"genre_scores_gemma":[0.00008007059,0.9914728,0.0008668776,0.0005006905,0.00226754,0.002659558,0.001406648,0.0003336101,0.0004121754],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9044418,"threshold_uncertainty_score":0.9993171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140016150","doi":"10.1517/14728214.2015.1050376","title":"Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Tardive dyskinesia; Neurochemical; Dopamine; Medicine; Dopamine receptor D2; Pharmacology; Antipsychotic; Monoamine neurotransmitter; Dyskinesia; Neuroscience; Dopamine receptor; Schizophrenia (object-oriented programming); Serotonin; Internal medicine; Receptor; Psychology; Psychiatry; Parkinson's disease","authors":[{"name":"Jonathan Lockwood","is_ca":true},{"name":"Gary Remington","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2655091623101564,"gpt":0.5465815142672025,"spread":0.2810723519570461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008474432,0.001199959,0.005885915,0.001344541,0.0004197326,0.0000954967,0.000396146,0.0007358713,0.0001425443],"category_scores_gemma":[0.002902134,0.0009255211,0.001468225,0.0008688324,0.0002509351,0.000241322,0.0002189491,0.001249755,0.00005021591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005211837,"about_ca_system_score_gemma":0.002286931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007868994,"about_ca_topic_score_gemma":0.000002937864,"domain_scores_codex":[0.9901991,0.001720993,0.003757405,0.001803088,0.001477022,0.0010424],"domain_scores_gemma":[0.9934073,0.002572186,0.001289155,0.0009744511,0.0003966519,0.001360252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008068103,0.002940299,0.000007510264,0.001387042,0.0008578133,0.00003852655,0.002523444,4.690326e-7,0.000005946123,0.0006312766,0.02113911,0.9624004],"study_design_scores_gemma":[0.08215375,0.003453853,0.00000587887,0.01297211,0.0003580435,0.00004249955,0.0008438444,0.0004695757,0.00002678902,0.0003728044,0.8984634,0.0008374069],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006084462,0.9780594,0.00005628659,0.004486807,0.003388509,0.0071976,0.000293148,0.0001703157,0.0002635193],"genre_scores_gemma":[0.002076619,0.9857223,0.002215621,0.0004344526,0.00399518,0.001971107,0.003102722,0.0002120387,0.0002699447],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9615631,"threshold_uncertainty_score":0.9993196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394581977","doi":"10.1080/14728214.2024.2340723","title":"Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Dalhousie University","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Clinical trial; Intensive care medicine; Pulmonary fibrosis; Disease; Lung; Internal medicine; Fibrosis","authors":[{"name":"S. Macisaac","is_ca":true},{"name":"Dujrath Somboonviboon","is_ca":true},{"name":"Ciaran Scallan","is_ca":true},{"name":"Martin Kolb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07169041454626408,"gpt":0.436137698945395,"spread":0.3644472843991309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002276108,0.0006273407,0.0017229,0.0007399529,0.0002350018,0.00005422396,0.0002454781,0.0003167347,0.0003891074],"category_scores_gemma":[0.0002347567,0.0005048458,0.0011062,0.0005539834,0.0001548924,0.0003079136,0.0000875469,0.0004758084,0.0001141052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003742579,"about_ca_system_score_gemma":0.0003209266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002712578,"about_ca_topic_score_gemma":0.00000210191,"domain_scores_codex":[0.9940242,0.0009577364,0.002378889,0.001200917,0.0007952165,0.0006430428],"domain_scores_gemma":[0.9977461,0.0003692284,0.0003594449,0.000932637,0.00009761612,0.0004950435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07266033,0.02608386,0.0004045095,0.0009067458,0.0008922688,0.0005775723,0.02986317,0.0001755603,0.02287569,0.006111781,0.01081576,0.8286328],"study_design_scores_gemma":[0.02359757,0.07438082,0.0006906099,0.02179687,0.0003668934,0.0001264598,0.007773532,0.04239421,0.006279545,0.0005332514,0.8199832,0.002077032],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9184664,0.05290958,0.0001589576,0.01300937,0.009634317,0.002135733,0.0002953855,0.0006245477,0.002765684],"genre_scores_gemma":[0.978662,0.01603501,0.0001709014,0.0006111028,0.00313352,0.0002198308,0.0005526941,0.0001190471,0.0004959522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8265557,"threshold_uncertainty_score":0.9997403,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4395667067","doi":"10.1080/14728214.2024.2346590","title":"Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Androgen receptor; Medicine; 5 Alpha-Reductase Inhibitor; Androgen; Finasteride; Pharmacology; Receptor; Internal medicine; Endocrinology; Prostate cancer; Hormone; Cancer","authors":[{"name":"Aditya K. Gupta","is_ca":true},{"name":"Mesbah Talukder","is_ca":true},{"name":"Greg Williams","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04625012959276738,"gpt":0.3528037797185237,"spread":0.3065536501257563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002724014,0.0006773113,0.001306369,0.0005261537,0.000268269,0.00008790066,0.0001070341,0.0003345631,0.0001656166],"category_scores_gemma":[0.00008129351,0.0005677961,0.000427395,0.0003384506,0.0001667198,0.00009012887,0.0000716043,0.0003838108,0.00005549453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001096877,"about_ca_system_score_gemma":0.0003120358,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001168454,"about_ca_topic_score_gemma":7.726056e-7,"domain_scores_codex":[0.9972827,0.00008000201,0.0007295302,0.001014491,0.0003962285,0.0004970356],"domain_scores_gemma":[0.9988887,0.0001346204,0.0001663459,0.0003166127,0.00005270683,0.0004409968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008818725,0.000128282,0.000007250928,0.01000684,0.0002980381,0.00001867589,0.001388744,2.183552e-7,0.00001580371,0.0005810371,0.1290759,0.858391],"study_design_scores_gemma":[0.001018984,0.000302422,0.000001030155,0.01221068,0.0001942664,0.0003210547,0.0005328561,0.00004525928,0.00003382731,0.00006391436,0.9847119,0.0005638454],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002434213,0.9932793,0.00001313933,0.001557767,0.00222662,0.001502408,0.0003855257,0.0001206138,0.000671256],"genre_scores_gemma":[0.0001277543,0.9936591,0.0006660474,0.000322625,0.002053767,0.0004859004,0.002068239,0.0001646152,0.0004519523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8578272,"threshold_uncertainty_score":0.9996774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147313898","doi":"10.1517/14728214.9.2.223","title":"Use of cytokines in infection","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Immune system; Immunology; Medicine; Adjuvant; Cytokine; Antimicrobial; Antibiotics; Vaccination; Infectious disease (medical specialty); Proinflammatory cytokine; Disease; Biology; Inflammation; Microbiology; Internal medicine","authors":[{"name":"Naoko Aoki","is_ca":true},{"name":"Zhou Xing","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1613996187446005,"gpt":0.4539644417797895,"spread":0.292564823035189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003049031,0.0003738425,0.0015188,0.001241375,0.00004054237,0.0000191609,0.0001207161,0.0003488761,0.0001859038],"category_scores_gemma":[0.00047793,0.0003133802,0.0004188893,0.000884922,0.0000709908,0.0001290852,0.00008117036,0.0006556093,0.0001362292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006179658,"about_ca_system_score_gemma":0.0005774084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002406082,"about_ca_topic_score_gemma":0.00001783035,"domain_scores_codex":[0.9974212,0.0002228002,0.0008549162,0.0004733192,0.000665174,0.0003625647],"domain_scores_gemma":[0.9987319,0.0002100757,0.0002443813,0.0005747356,0.000104681,0.0001342427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002526776,0.0002179287,0.0001122012,0.007775032,0.00006513101,0.00001618898,0.0004340496,0.000009116974,0.000003067343,0.0001565476,0.001452126,0.9897333],"study_design_scores_gemma":[0.0004350634,0.0001641571,0.00004880833,0.06139858,0.0000109813,0.000009000814,0.000008972177,0.00002084204,0.00002298103,0.000005018587,0.9376588,0.0002168064],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000458995,0.9966783,0.0000187289,0.0001791167,0.000869597,0.0009989254,0.0000167371,0.00007298071,0.001119718],"genre_scores_gemma":[0.0001057605,0.9985138,0.0002052692,0.00007198386,0.0003939764,0.0001846147,0.000204157,0.00009661336,0.000223788],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9895166,"threshold_uncertainty_score":0.9999318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985544005","doi":"10.1517/14728214.2013.811487","title":"Inflammation and the heart – prime time for new therapeutic approaches","year":2013,"lang":"en","type":"letter","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Coronary artery disease; Inflammation; Disease; Intensive care medicine; Clinical trial; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine","authors":[{"name":"François Roubille","is_ca":true},{"name":"Jean‐Claude Tardif","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.037059422539979,"gpt":0.2852610698547764,"spread":0.2482016473147974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006740604,0.0003484789,0.0007006694,0.0001263731,0.0002033993,0.00007086136,0.0001290553,0.0004325524,0.00008969975],"category_scores_gemma":[0.000064924,0.0002144711,0.0004358703,0.00009030716,0.0001014077,0.00007494906,0.00004051374,0.0006966548,0.00009248178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008042729,"about_ca_system_score_gemma":0.0001833291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002646425,"about_ca_topic_score_gemma":1.786634e-7,"domain_scores_codex":[0.9979638,0.00019691,0.0003678925,0.0004817807,0.0006129267,0.0003766284],"domain_scores_gemma":[0.9986771,0.0002290485,0.0001549091,0.0007745805,0.00006456554,0.00009982387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001437891,0.00001256252,0.000001559587,0.0001837612,0.0003126197,7.557344e-7,0.001842494,0.00000198315,0.00005802911,0.0002603228,0.8303151,0.1668671],"study_design_scores_gemma":[0.003011616,0.0001357418,0.0000394522,0.000318265,0.0000363905,0.00002597529,0.00009466861,0.001327612,0.0003168349,0.0002325808,0.9942217,0.0002391478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001732716,0.01816286,0.000778452,0.9753612,0.0007704358,0.003589825,0.000003952153,0.0001173982,0.001042619],"genre_scores_gemma":[0.001240866,0.00572525,0.002192181,0.9069558,0.05943813,0.002075645,0.001151481,0.0003324465,0.02088817],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1666279,"threshold_uncertainty_score":0.8745878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2335279309","doi":"10.1517/14728214.2016.1170117","title":"Emerging drugs for graft-versus-host disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Disease; Clinical trial; Graft-versus-host disease; Immunology; Intensive care medicine; Internal medicine","authors":[{"name":"Natasha Kekre","is_ca":true},{"name":"Joseph H. Antin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05485852904322683,"gpt":0.3932086352117313,"spread":0.3383501061685044,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005370484,0.001054634,0.002174242,0.0006758462,0.000309821,0.00005241464,0.0004081454,0.000414555,0.0005341654],"category_scores_gemma":[0.0002209064,0.0008008613,0.001455237,0.0004213862,0.0001050715,0.0001570566,0.00006534871,0.0004210167,0.0006627415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004522103,"about_ca_system_score_gemma":0.000588078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001382586,"about_ca_topic_score_gemma":3.105804e-7,"domain_scores_codex":[0.9952368,0.0002003684,0.001347842,0.001314181,0.0009937254,0.0009070694],"domain_scores_gemma":[0.9962587,0.001131184,0.0005576114,0.001165204,0.0001690545,0.0007182109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007372214,0.0002203477,0.000001886829,0.02201208,0.0005059118,0.00002512331,0.002306734,5.164204e-7,0.000008205468,0.001995479,0.01851567,0.9536708],"study_design_scores_gemma":[0.003265673,0.0001735865,0.000001654191,0.06673377,0.0002892839,0.00001300726,0.0003187948,0.00003386486,0.00002553762,0.00002211109,0.9283015,0.0008212805],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003211923,0.9823596,0.001362784,0.002091931,0.00721321,0.003068493,0.0002529538,0.0003997538,0.003248033],"genre_scores_gemma":[0.00003106618,0.9911976,0.0006544629,0.0003935151,0.002764019,0.001376624,0.001379884,0.0003583769,0.001844417],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9528496,"threshold_uncertainty_score":0.9994442,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067328075","doi":"10.1517/14728210903203790","title":"Antigen-specific therapies in multiple sclerosis","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Effector; Antigen; Immunology; Immune system; Neuroscience; Biology","authors":[{"name":"Paul S. Giacomini","is_ca":true},{"name":"Amit Bar‐Or","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2141295040898592,"gpt":0.4057707716530308,"spread":0.1916412675631716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006481285,0.0009224781,0.002845141,0.001230047,0.0002803755,0.0000745304,0.0004739707,0.0004113794,0.0002244802],"category_scores_gemma":[0.000296136,0.0007140079,0.0008760651,0.001043771,0.0001888576,0.000117367,0.0001764099,0.001105593,0.0003608686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005666886,"about_ca_system_score_gemma":0.0001910677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009796218,"about_ca_topic_score_gemma":0.000005270781,"domain_scores_codex":[0.9951315,0.0004009489,0.001162127,0.001179639,0.00115344,0.0009723743],"domain_scores_gemma":[0.9977026,0.0004878345,0.000309155,0.001108638,0.0001233814,0.0002683871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006522473,0.0003992855,0.00003868644,0.0009483537,0.0001751721,0.000009925239,0.002207267,0.000001089358,0.00002724762,0.00004126852,0.01728018,0.9788063],"study_design_scores_gemma":[0.001410492,0.0001845945,0.0009243577,0.0509734,0.000004529406,0.000004830129,0.0004763,0.00002464467,0.00001530297,0.000003188166,0.945401,0.0005773447],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003333079,0.9943253,0.00001141606,0.00112145,0.001003431,0.001875305,0.00002196792,0.0002197161,0.001388071],"genre_scores_gemma":[0.0003219916,0.996552,0.0005241066,0.0003192182,0.001308197,0.0004862772,0.0001864388,0.0001634307,0.0001383392],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782289,"threshold_uncertainty_score":0.9995311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974479297","doi":"10.1517/14728214.2014.955014","title":"Emerging drugs for levodopa-induced dyskinesia","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Levodopa; Medicine; Dyskinesia; Intensive care medicine; Disease; Parkinson's disease; Internal medicine","authors":[{"name":"Amaal Al Dakheel","is_ca":true},{"name":"Isabelle Beaulieu‐Boire","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05619929424255898,"gpt":0.3902307493660356,"spread":0.3340314551234767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004919016,0.0013166,0.003204768,0.0007724242,0.000424058,0.00007194163,0.000427248,0.0005406278,0.0002487881],"category_scores_gemma":[0.0001450742,0.001069088,0.001817514,0.0004861276,0.00004118092,0.0001181333,0.0001221321,0.0004946445,0.000428752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005111348,"about_ca_system_score_gemma":0.0004299283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005060306,"about_ca_topic_score_gemma":5.1627e-7,"domain_scores_codex":[0.9951764,0.0002146212,0.001176137,0.001561526,0.0008673757,0.001003954],"domain_scores_gemma":[0.9969165,0.00030623,0.0007131961,0.001288889,0.0001656218,0.0006095156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001066026,0.0004045258,0.000001198135,0.005369862,0.0006561139,0.00002029583,0.0005629666,6.402028e-7,0.000007129121,0.001064531,0.01270303,0.9791031],"study_design_scores_gemma":[0.00252721,0.0004257945,0.000003088366,0.01960748,0.0003836988,0.00003216992,0.0001850518,0.0001523735,0.00004975252,0.00006354936,0.9756561,0.0009137296],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003022098,0.9881489,0.0005278806,0.0007203352,0.004502331,0.00281154,0.0000841827,0.0004128585,0.002761779],"genre_scores_gemma":[0.0004394846,0.9897496,0.001028415,0.0007852162,0.003065472,0.001671064,0.001454302,0.0004145956,0.001391817],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9781893,"threshold_uncertainty_score":0.9999585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075748215","doi":"10.1517/14728214.2015.985204","title":"Emerging drugs for celiac disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Internal medicine","authors":[{"name":"Hugh James Freeman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04708593854982716,"gpt":0.4214706061184548,"spread":0.3743846675686276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008226558,0.001010937,0.002361227,0.0009302011,0.0003790944,0.0001103172,0.0005306276,0.0002403932,0.000469218],"category_scores_gemma":[0.0004352492,0.000837966,0.002114068,0.0005117301,0.0001039078,0.0001153664,0.0003153714,0.0005660882,0.0005813288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004718146,"about_ca_system_score_gemma":0.0006462458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002985327,"about_ca_topic_score_gemma":3.014056e-7,"domain_scores_codex":[0.9946065,0.0002385467,0.001095991,0.001428835,0.00137411,0.001256036],"domain_scores_gemma":[0.9959533,0.0003840296,0.000410594,0.00155733,0.0001926589,0.001502036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001900131,0.0002797468,5.53163e-7,0.02080384,0.0003490743,0.00001473782,0.0002256972,0.000002167719,2.733271e-7,0.001466438,0.1969296,0.7797379],"study_design_scores_gemma":[0.00149125,0.0002082824,0.000001383629,0.02642606,0.0002647492,0.000002582997,0.0002200064,0.0002872375,0.000001591518,0.00006060264,0.970247,0.0007893048],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[5.905401e-7,0.9844673,0.000722102,0.003368888,0.002650506,0.004107061,0.0001267785,0.0003366709,0.004220095],"genre_scores_gemma":[0.00001037089,0.9839794,0.0003018687,0.001353876,0.0038299,0.002669902,0.002431305,0.0003113539,0.005112032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7789485,"threshold_uncertainty_score":0.9994071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001823700","doi":"10.1517/14728210903142147","title":"Emerging drugs for prostate cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Angiogenesis; Androgen receptor; Pharmacology; Matrix metalloproteinase inhibitor; Tyrosine kinase; Cancer; Cancer research; Matrix metalloproteinase; Internal medicine; Receptor","authors":[{"name":"Kashif Siddiqui","is_ca":true},{"name":"Laurence Klotz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0657725239338676,"gpt":0.4459334391320053,"spread":0.3801609151981378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004458347,0.0009618743,0.002315166,0.0007156483,0.0004027122,0.00007845469,0.0003538212,0.0003925847,0.0002800934],"category_scores_gemma":[0.00006446613,0.0007014549,0.001130803,0.0006689191,0.0001010538,0.0001305492,0.00009417763,0.0007338672,0.0001142413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009959801,"about_ca_system_score_gemma":0.001077219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001193667,"about_ca_topic_score_gemma":0.000001238618,"domain_scores_codex":[0.9956538,0.0001341589,0.0009507207,0.001216621,0.0008904764,0.001154222],"domain_scores_gemma":[0.9979048,0.0002161307,0.0004169881,0.0008063744,0.0002317489,0.000423892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000248364,0.0002033502,0.000001848917,0.005924567,0.0004165106,0.00001247511,0.002467379,0.000001765197,0.00000298395,0.0001065067,0.05837652,0.9322377],"study_design_scores_gemma":[0.002304681,0.0004805795,0.000001237454,0.03461453,0.0001384089,0.00001082641,0.0003694491,0.00005607347,0.000051123,0.00003288501,0.9612657,0.0006745157],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004216014,0.9855648,0.00001775903,0.004652578,0.002438707,0.004327643,0.0001574601,0.0002688224,0.00256799],"genre_scores_gemma":[0.000007135148,0.9795104,0.0003017543,0.0007155634,0.002712297,0.003304137,0.001398466,0.000247752,0.01180255],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9315632,"threshold_uncertainty_score":0.9995437,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2548436673","doi":"10.1080/14728214.2016.1257607","title":"Emerging drugs and therapeutics for systemic sclerosis","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Context (archaeology); Scleroderma (fungus); Interstitial lung disease; Multiple sclerosis; Systemic disease; Bioinformatics; Immunology; Pathology; Lung; Internal medicine","authors":[{"name":"Jason J. Lee","is_ca":true},{"name":"Janet Pope","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07706061920886499,"gpt":0.3731720748649865,"spread":0.2961114556561216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005230745,0.000902285,0.00241375,0.0005306573,0.0003501865,0.0000762247,0.0002881586,0.0006754277,0.00006820446],"category_scores_gemma":[0.00007393736,0.0005786144,0.001078246,0.0003278052,0.0001133333,0.00009295729,0.00008715589,0.0003536911,0.0001113573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003301744,"about_ca_system_score_gemma":0.0002862819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001453485,"about_ca_topic_score_gemma":4.399623e-8,"domain_scores_codex":[0.996056,0.0002191734,0.00132015,0.00108574,0.00063295,0.0006859578],"domain_scores_gemma":[0.9973848,0.0004991057,0.0007033878,0.0008733958,0.0001675649,0.0003717743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005914678,0.00009746864,0.000002288657,0.009081059,0.0007357835,0.000001796129,0.001369882,2.340803e-7,0.00005225592,0.0002561547,0.008728474,0.9796154],"study_design_scores_gemma":[0.001295529,0.0001217383,0.000001376644,0.276769,0.0002706276,0.0000729711,0.0008251119,0.00002896135,0.00001408691,0.000006713309,0.7200826,0.0005113078],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002895586,0.9927651,0.0001064942,0.001104516,0.00283981,0.00237406,0.000064789,0.0002788629,0.0004373866],"genre_scores_gemma":[0.0003862351,0.9945433,0.00009169629,0.0007458853,0.002182786,0.0008895646,0.000151377,0.000276181,0.0007330166],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9791042,"threshold_uncertainty_score":0.9996665,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399261264","doi":"10.1080/14728214.2024.2363215","title":"Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Weston Brain Institute","keywords":"Apathy; Medicine; Psychosis; Psychiatry; Disease; Adverse effect; Dementia; Cognitive decline; Alzheimer's disease; Intensive care medicine; Cognition; Pharmacology; Internal medicine","authors":[{"name":"Hui Jue Wang","is_ca":true},{"name":"Arun Chinna‐Meyyappan","is_ca":true},{"name":"Oriel J. Feldman","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1089756636526861,"gpt":0.4756428104654163,"spread":0.3666671468127302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002858001,0.0005771323,0.001444849,0.0009748146,0.00008378226,0.00004038835,0.0001595559,0.000131481,0.0002470629],"category_scores_gemma":[0.0000910549,0.0003711423,0.0008329179,0.0006260111,0.00007227392,0.00007828317,0.00003527867,0.0001392547,0.00006022534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001830865,"about_ca_system_score_gemma":0.0004381749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004401503,"about_ca_topic_score_gemma":0.000003960914,"domain_scores_codex":[0.9971656,0.0001571612,0.0008867493,0.0007442426,0.0005792243,0.0004670025],"domain_scores_gemma":[0.998656,0.0002668398,0.0002196483,0.000445768,0.0001928968,0.0002187952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004428215,0.000997261,0.0000490749,0.004701007,0.001008077,0.00001844124,0.00307117,3.146488e-7,0.000001135954,0.0001773909,0.008423957,0.9811093],"study_design_scores_gemma":[0.001632459,0.00118981,0.00005449076,0.0226343,0.0005041042,0.000003460449,0.001136849,0.00005528685,0.00001288197,0.00005770429,0.9723893,0.0003293262],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002593801,0.9930167,0.00004560158,0.001922809,0.001098846,0.003319775,0.0001205038,0.00007541561,0.000374406],"genre_scores_gemma":[0.000209625,0.993351,0.0002009601,0.0002106246,0.0005738373,0.003568241,0.0008854673,0.0001309592,0.0008692176],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.98078,"threshold_uncertainty_score":0.9998741,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122042922","doi":"10.1517/14728214.2012.681301","title":"Emerging drugs for major depressive disorder: an update","year":2012,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Major depressive disorder; Psychiatry; Pharmacology; Mood","authors":[{"name":"Sakina J. Rizvi","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01387667962968207,"gpt":0.3389484737818395,"spread":0.3250717941521574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000610057,0.001404239,0.001569597,0.0007234517,0.0007412743,0.0001225386,0.0007121207,0.001454534,0.0005134052],"category_scores_gemma":[0.0006098194,0.001231238,0.0007369409,0.000292968,0.000129804,0.0005951783,0.0002943438,0.00130502,0.0002508286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005145784,"about_ca_system_score_gemma":0.0003682429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003012316,"about_ca_topic_score_gemma":0.000007037772,"domain_scores_codex":[0.9930096,0.0002458386,0.001100275,0.001868697,0.002289709,0.001485925],"domain_scores_gemma":[0.9951361,0.0008207802,0.0008345878,0.001947782,0.0004538704,0.000806908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00146654,0.001096248,0.00009996644,0.0002970929,0.0004295205,0.00001030971,0.004020165,0.00001506857,0.0001967346,0.0001050596,0.913377,0.07888634],"study_design_scores_gemma":[0.009766604,0.0007221829,0.00005097139,0.001862052,0.0001808221,0.000005282799,0.0009639775,0.0002479601,0.001166845,0.00007637429,0.9837589,0.001198066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.001068977,0.03041265,0.0006436944,0.004148804,0.9576156,0.002899722,0.0005169112,0.001002791,0.001690853],"genre_scores_gemma":[0.004491134,0.01119155,0.003186762,0.0006896248,0.958465,0.001925451,0.01559782,0.0008387165,0.003613939],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.07768827,"threshold_uncertainty_score":0.9998708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4365811101","doi":"10.1080/14728214.2023.2203912","title":"Emerging drugs in the treatment of chronic cough","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Chronic cough; Intensive care medicine; Narrative review; Disease; Expert opinion; Bioinformatics; Internal medicine; Asthma","authors":[{"name":"Danica Brister","is_ca":true},{"name":"Mustafaa Wahab","is_ca":true},{"name":"Moaaz Rashad","is_ca":true},{"name":"Nermin Diab","is_ca":true},{"name":"Martin Kolb","is_ca":true},{"name":"Imran Satia","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1032706225972402,"gpt":0.4426686503978257,"spread":0.3393980278005855,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009130894,0.0006756969,0.001993052,0.0008254888,0.0001970149,0.00003156764,0.0005193235,0.0004321976,0.000241883],"category_scores_gemma":[0.00006943562,0.0004068564,0.000915583,0.001596427,0.0001407916,0.00006793355,0.0000633539,0.0008328902,0.0004005974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008498076,"about_ca_system_score_gemma":0.0008051488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001658963,"about_ca_topic_score_gemma":0.000004037563,"domain_scores_codex":[0.9954638,0.0006288066,0.001223771,0.0007706538,0.001193692,0.0007193114],"domain_scores_gemma":[0.9975629,0.0006384287,0.0003790731,0.001194695,0.00007932747,0.0001455166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005709494,0.0006769751,0.000002126477,0.003874295,0.0003636224,0.00006482338,0.008806909,0.00001426999,0.000002301603,0.0003158556,0.005476053,0.9803457],"study_design_scores_gemma":[0.001200771,0.001134985,0.000004311139,0.02287583,0.00006888899,0.00001615218,0.00184512,0.00009564795,0.00001700706,0.00001101443,0.9724053,0.0003249549],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009001471,0.9925179,0.000002775711,0.000893501,0.001302321,0.001891797,0.00001649607,0.000111776,0.003173343],"genre_scores_gemma":[0.00009831916,0.9954846,0.000008741928,0.0001256685,0.001449073,0.000826008,0.0002032205,0.0001463143,0.001658073],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9800207,"threshold_uncertainty_score":0.9998384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379598629","doi":"10.1080/14728214.2023.2218643","title":"Emerging peptide therapeutics for the treatment of ovarian cancer","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Peptide; Oncology; Internal medicine; Cancer research; Biology; Biochemistry","authors":[{"name":"Ana Veneziani","is_ca":true},{"name":"Eduardo González-Ochoa","is_ca":true},{"name":"Amit M. Oza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09083098333692492,"gpt":0.4018117388492976,"spread":0.3109807555123727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003404877,0.0006507357,0.001511226,0.0003095111,0.0005510303,0.00002234177,0.0005664793,0.0004470721,0.0002976974],"category_scores_gemma":[0.00002845962,0.0003924542,0.001172215,0.0003510718,0.0001887743,0.00004270811,0.0000436777,0.0002715467,0.0001542603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002045566,"about_ca_system_score_gemma":0.0002879009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003811878,"about_ca_topic_score_gemma":0.000004551371,"domain_scores_codex":[0.9975172,0.0004353238,0.0008937006,0.0005030673,0.00008501238,0.000565735],"domain_scores_gemma":[0.9966234,0.001866598,0.0005913689,0.0008280808,0.00007497917,0.00001557666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000281973,0.0002055002,2.97411e-7,0.0005421246,0.003224649,3.798967e-7,0.005157569,0.000006225404,0.0001931413,0.0003762251,0.003855625,0.9861563],"study_design_scores_gemma":[0.001129426,0.0005062033,0.000001903802,0.004413225,0.0001814853,0.00000561319,0.0007613799,0.000006562155,0.0006781816,0.00001092891,0.9919055,0.0003995528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000576378,0.9899228,0.00008843443,0.0006932802,0.00734129,0.001560247,0.0001742979,0.0001300628,0.00008387494],"genre_scores_gemma":[0.000008292844,0.989006,0.00002522182,0.0001698788,0.0003763915,0.001785575,0.0003136219,0.0001652645,0.008149742],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9880499,"threshold_uncertainty_score":0.9998527,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404445324","doi":"10.1080/14728214.2024.2426649","title":"ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; McGill University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Glioma; Cancer research","authors":[{"name":"Jordan R. Hansford","is_ca":false},{"name":"Neevika Manoharan","is_ca":false},{"name":"Gauthier Bouche","is_ca":false},{"name":"Vijay Ramaswamy","is_ca":true},{"name":"Nada Jabado","is_ca":true},{"name":"Éric Bouffet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06663130938689137,"gpt":0.4072833999992634,"spread":0.340652090612372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007546783,0.0007343796,0.001705473,0.0008624163,0.00005410808,0.00003800067,0.0004246788,0.000425437,0.0004382089],"category_scores_gemma":[0.002562427,0.0004731004,0.0003856804,0.001179591,0.00005726024,0.0001127618,0.0002785287,0.000727883,0.0004686854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003863071,"about_ca_system_score_gemma":0.0005958123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007292437,"about_ca_topic_score_gemma":0.00002416606,"domain_scores_codex":[0.9951004,0.0001597399,0.00128039,0.001194044,0.001719111,0.0005462808],"domain_scores_gemma":[0.9967736,0.0009451407,0.0003369536,0.001288988,0.0003197433,0.0003355951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006192374,0.001298316,0.00001356338,0.007550319,0.0001557638,0.0003881003,0.0008076076,0.000001599075,0.0002435812,0.00001531891,0.9732593,0.01564734],"study_design_scores_gemma":[0.001958503,0.0008560426,0.00002182077,0.1932649,0.00006780771,0.000009470568,0.00007227323,0.00001508295,0.001011839,0.000003473072,0.802335,0.0003837468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"review","genre_scores_codex":[0.001227179,0.3532554,0.000003353759,0.0213297,0.620971,0.00254467,0.0001638678,0.0001481846,0.0003566745],"genre_scores_gemma":[0.0007844681,0.6556579,0.0006632374,0.001675102,0.3374521,0.001261225,0.0009691423,0.0002310235,0.001305804],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.3024025,"threshold_uncertainty_score":0.9997721,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390744213","doi":"10.1080/14728214.2024.2303116","title":"Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Janus kinase; Clinical trial; Disease; Vedolizumab; Narrative review; Inflammatory bowel disease; Intensive care medicine; Bioinformatics; Pharmacology; Immunology; Internal medicine; Cytokine","authors":[{"name":"Panu Wetwittayakhlang","is_ca":true},{"name":"Talat Bessissow","is_ca":true},{"name":"Péter L. Lakatos","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05332353335246805,"gpt":0.4074374476504162,"spread":0.3541139142979482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008111731,0.00057069,0.00160674,0.0001274314,0.0001702599,0.00002057621,0.0002174078,0.0001576822,0.00002331773],"category_scores_gemma":[0.0002511395,0.0003567564,0.0009994933,0.0001176917,0.0001468025,0.000005977698,0.0001409205,0.00008080607,0.000001026506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004108898,"about_ca_system_score_gemma":0.0003006547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001095779,"about_ca_topic_score_gemma":4.673589e-7,"domain_scores_codex":[0.9973928,0.0002032228,0.001213327,0.0006818123,0.0002465109,0.0002623185],"domain_scores_gemma":[0.9981446,0.0001866788,0.0007051601,0.0006953742,0.00009920212,0.0001690158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000465981,0.0004929078,2.317195e-7,0.04947168,0.0009796938,0.000005088926,0.0007449501,6.803673e-7,0.0001028286,0.0002703955,0.00841265,0.9390529],"study_design_scores_gemma":[0.001858002,0.0003463472,0.000002022011,0.03621742,0.0008447823,0.000003148678,0.0001009633,0.00003754973,0.00005724181,0.000006491082,0.9601965,0.0003295584],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001322311,0.9952171,0.00007737472,0.0003370604,0.0007542846,0.002684232,0.0007449665,0.00001541328,0.0000372655],"genre_scores_gemma":[0.00007570589,0.9968586,0.00009826461,0.000154709,0.0006885746,0.001145117,0.0005998348,0.00008577905,0.0002934294],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9517838,"threshold_uncertainty_score":0.9998884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144409780","doi":"10.1517/14728214.6.2.281","title":"Pharmacological treatment for prevention of restenosis","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"Pfizer","keywords":"Restenosis; Medicine; Intimal hyperplasia; Neointimal hyperplasia; Cardiology; Angioplasty; Coronary artery disease; Conventional PCI; Internal medicine; Percutaneous coronary intervention; Neointima; Interventional cardiology; Stent; Myocardial infarction; Smooth muscle","authors":[{"name":"Jacek Linde","is_ca":true},{"name":"Bradley H. Strauss","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08141778822303335,"gpt":0.4207583856965823,"spread":0.3393405974735489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006786648,0.0001046706,0.000190126,0.0000905537,0.00006054933,0.000004056312,0.0000405338,0.0000465379,0.0005224387],"category_scores_gemma":[0.00005456266,0.00008223212,0.0002457792,0.00009105032,0.00002351011,0.00003186,0.000012633,0.00003579926,0.00001251112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008791745,"about_ca_system_score_gemma":0.00002238811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002618382,"about_ca_topic_score_gemma":9.66316e-7,"domain_scores_codex":[0.9992682,0.00002575925,0.0002559857,0.0001789758,0.0001297459,0.0001413315],"domain_scores_gemma":[0.9995193,0.0001297617,0.0000740617,0.0001390321,0.00006920486,0.00006867605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004123987,0.01074908,0.006578841,0.00009296414,0.000531439,0.00002341484,0.002821096,0.0001588321,0.01191859,0.004694113,0.06792331,0.8903843],"study_design_scores_gemma":[0.00775588,0.009654074,0.007478079,0.0006196846,0.00006371621,0.00002496621,0.001129007,0.001790237,0.02105839,0.0002733551,0.9499407,0.0002119145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.964562,0.005303047,0.004588997,0.01348618,0.002406372,0.001955747,0.0000317244,0.000177475,0.007488457],"genre_scores_gemma":[0.9891104,0.006396126,0.0013849,0.000311305,0.0003952405,0.000253756,0.00009922293,0.00001635483,0.00203266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8901724,"threshold_uncertainty_score":0.5720338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391402131","doi":"10.1080/14728214.2024.2312817","title":"How will tovorafenib change our treatment of pediatric low-grade glioma?","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Oncology; Intensive care medicine; Cancer research","authors":[{"name":"İnci Yaman Bajin","is_ca":true},{"name":"Éric Bouffet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03407019048588678,"gpt":0.3377245327762583,"spread":0.3036543422903715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001264179,0.0009843028,0.001423363,0.0009399714,0.0001136833,0.00009932968,0.0002229804,0.0008188309,0.00004199164],"category_scores_gemma":[0.0001249454,0.000746803,0.0008768007,0.0007068557,0.00003574938,0.0001474957,0.00008622472,0.0004045223,0.0001198075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007865113,"about_ca_system_score_gemma":0.0002794151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003809911,"about_ca_topic_score_gemma":0.000004578806,"domain_scores_codex":[0.995833,0.00008631794,0.0006275573,0.001172341,0.001619544,0.0006612501],"domain_scores_gemma":[0.9977946,0.0002518613,0.0003919945,0.0009731925,0.0002280493,0.0003603598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001921443,0.002595834,0.00006432516,0.0004714022,0.0006454766,0.000359237,0.003156496,0.000001147732,0.0001182078,0.00005669889,0.9822366,0.01010248],"study_design_scores_gemma":[0.004375028,0.002396748,0.00002834822,0.001162186,0.0002622141,0.000009954781,0.0007359789,0.00002948935,0.002999409,0.00001685356,0.9874194,0.0005643606],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.003905813,0.09747001,0.000001637925,0.01362257,0.8824698,0.001568409,0.0004520851,0.0003059565,0.0002037387],"genre_scores_gemma":[0.03192396,0.08023939,0.0001205489,0.00008031714,0.8827962,0.001257493,0.002220556,0.0002638895,0.001097624],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.02801814,"threshold_uncertainty_score":0.9994983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399385857","doi":"10.1080/14728214.2024.2363213","title":"Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Hyperplasia; cGMP-specific phosphodiesterase type 5; Benign prostatic hyperplasia (BPH); Intensive care medicine; Primary care; Primary treatment; Modalities; 5 Alpha-Reductase Inhibitor; Urology; Prostate; Internal medicine; Gynecology; Erectile dysfunction; Finasteride; Cancer; Family medicine","authors":[{"name":"Joshua Winograd","is_ca":false},{"name":"Nikit Venishetty","is_ca":false},{"name":"Alia Codelia‐Anjum","is_ca":false},{"name":"Naeem Bhojani","is_ca":true},{"name":"Dean Elterman","is_ca":true},{"name":"Kevin C. Zorn","is_ca":true},{"name":"Alexis E. Te","is_ca":false},{"name":"Bilal Chughtai","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07313921420710602,"gpt":0.4351080879869832,"spread":0.3619688737798772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005825481,0.0008576859,0.00211196,0.0006456884,0.0003170279,0.00007144905,0.0003632098,0.0002612941,0.0002448058],"category_scores_gemma":[0.00006268974,0.0004868195,0.001401412,0.0008010644,0.0001495511,0.00007424203,0.0001012318,0.0005128652,0.0002797435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003971042,"about_ca_system_score_gemma":0.00076441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009398223,"about_ca_topic_score_gemma":0.000001411227,"domain_scores_codex":[0.996038,0.0002084285,0.001117392,0.000963891,0.0008692466,0.0008030506],"domain_scores_gemma":[0.9973922,0.0008823532,0.000296247,0.001040134,0.0001507167,0.0002383073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002052803,0.0004910086,4.868102e-7,0.01234681,0.001378835,0.0000253584,0.007074992,0.000002724897,0.000001952446,0.000498187,0.0351933,0.9427811],"study_design_scores_gemma":[0.001151742,0.001917679,2.988581e-7,0.0142924,0.0005830879,0.00006214869,0.001677907,0.0003556011,0.00002875516,0.00005761614,0.9794673,0.000405413],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000566179,0.9873476,0.00004265258,0.003689446,0.002061163,0.005065924,0.0002964447,0.0001237327,0.001367352],"genre_scores_gemma":[0.00003170273,0.9885935,0.0002814324,0.0001109448,0.001315089,0.003004078,0.0009136848,0.0002421967,0.005507359],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9442741,"threshold_uncertainty_score":0.9997584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019398901","doi":"10.1517/14728214.11.2.217","title":"Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Reverse transcriptase; Pharmacology; Nucleoside Reverse Transcriptase Inhibitor; Reverse-transcriptase inhibitor; Dosing; Drug; Regimen; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load; Internal medicine; Biology; RNA","authors":[{"name":"Claude Fortin","is_ca":true},{"name":"Véronique Joly","is_ca":false},{"name":"Patrick Yéni","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03402692502663547,"gpt":0.3494930753719826,"spread":0.3154661503453471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002371242,0.0007027134,0.001632321,0.0006881059,0.0001633441,0.00001364333,0.0001079194,0.0002599727,0.00005562712],"category_scores_gemma":[0.00002973535,0.0004435569,0.001060297,0.0005735517,0.00005926429,0.00008568658,0.0000134398,0.0001991975,0.00002928593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007773846,"about_ca_system_score_gemma":0.0002390932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004324845,"about_ca_topic_score_gemma":0.00002625918,"domain_scores_codex":[0.9972387,0.0001186896,0.001158908,0.000640226,0.0004072592,0.0004362339],"domain_scores_gemma":[0.9986366,0.0002741959,0.0004027556,0.000513765,0.00006997416,0.0001027099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002118944,0.001368778,0.0001134738,0.003240374,0.0004124516,0.00001113228,0.005360885,0.00001140514,7.348012e-7,0.00007583389,0.0260777,0.9631153],"study_design_scores_gemma":[0.003607144,0.0003707622,0.00001664418,0.02046376,0.0002118694,0.000007869842,0.0002930301,0.00008663865,0.00004968659,0.000003674813,0.9745359,0.0003530291],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008444631,0.9923139,0.00007591548,0.001485231,0.001889543,0.003624791,0.00006974859,0.00008190764,0.0003745505],"genre_scores_gemma":[0.0000636862,0.9927502,0.0002926594,0.00004677149,0.0007705109,0.001679532,0.00129988,0.000106356,0.002990399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9627623,"threshold_uncertainty_score":0.9998016,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394816071","doi":"10.1080/14728214.2024.2339906","title":"Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Head and neck; Incidence (geometry); Monoclonal antibody; Head and neck cancer; Immunotherapy; Antibody; Cancer; Immunology; Surgery","authors":[{"name":"Francis Proulx-Rocray","is_ca":true},{"name":"Denis Soulières","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03019522110742881,"gpt":0.3631607518519307,"spread":0.3329655307445019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001666404,0.0002816598,0.0003934252,0.0001946447,0.0002550853,0.0000440863,0.00007128042,0.00008082799,0.00007026222],"category_scores_gemma":[0.00002118094,0.000230499,0.0001616829,0.0001926232,0.00005443513,0.00009373829,0.0000395187,0.0001914153,0.00001810409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007398966,"about_ca_system_score_gemma":0.00009681239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001305336,"about_ca_topic_score_gemma":0.000001487334,"domain_scores_codex":[0.9984382,0.00002607148,0.0002885435,0.0005508533,0.0002777944,0.0004185422],"domain_scores_gemma":[0.9993694,0.0001516651,0.00003623803,0.0002312325,0.00005702157,0.000154437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002960488,0.001035243,0.01298355,0.001506374,0.000313793,0.0001092906,0.07978518,0.00003151467,0.06553742,0.003656751,0.2400831,0.5919973],"study_design_scores_gemma":[0.003725327,0.001546603,0.005803371,0.0004685191,0.000008451734,0.0000185732,0.001577649,0.005094952,0.01009628,0.00006251902,0.9712231,0.0003746642],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8435725,0.132014,0.0002718506,0.01516842,0.003069874,0.0007210556,0.0000210881,0.0002938511,0.004867388],"genre_scores_gemma":[0.9854704,0.009713608,0.000621439,0.001745236,0.001388081,0.0001366739,0.00006011,0.00007420361,0.0007902876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.73114,"threshold_uncertainty_score":0.9399475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4406242635","doi":"10.1080/14728214.2025.2452514","title":"Seltorexant for major depressive disorder","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Major depressive disorder; Tolerability; Orexin; Medicine; Preclinical research; Cognition; Psychiatry; Neuroscience; Pharmacology; Clinical psychology; Psychology; Internal medicine; Receptor; Adverse effect; Neuropeptide","authors":[{"name":"Kyle Valentino","is_ca":true},{"name":"Kayla M. Teopiz","is_ca":true},{"name":"Sabrina Wong","is_ca":true},{"name":"M Zhang","is_ca":true},{"name":"Gia Han Le","is_ca":true},{"name":"Hayun Choi","is_ca":true},{"name":"Hana Ballum","is_ca":true},{"name":"Christine E. Dri","is_ca":true},{"name":"William W. L. Cheung","is_ca":true},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07306809664989065,"gpt":0.4213677283415115,"spread":0.3482996316916209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002552231,0.0006475505,0.001287076,0.0006200501,0.0006064352,0.0001340255,0.001101357,0.0003380201,0.0001774369],"category_scores_gemma":[0.001389505,0.0005048893,0.0007633005,0.0007741326,0.0001114996,0.0001246266,0.0003171589,0.0005431494,0.0001594019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001483708,"about_ca_system_score_gemma":0.0003712364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002883038,"about_ca_topic_score_gemma":6.752877e-7,"domain_scores_codex":[0.9960656,0.0004156894,0.0006460188,0.001359685,0.0007190549,0.0007939396],"domain_scores_gemma":[0.9962547,0.002352601,0.0002689822,0.0008732035,0.00007652624,0.0001739309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002558676,0.0001317927,3.022228e-7,0.003704699,0.00003752013,0.000004031003,0.0002398641,0.000002791097,0.000004581574,0.002745031,0.02179188,0.9713119],"study_design_scores_gemma":[0.0005916451,0.00006287592,1.18326e-7,0.00974432,0.00001888545,0.000003909236,0.00005465813,0.00008249919,0.0003875901,0.00009048534,0.9884334,0.0005296724],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[6.804299e-7,0.9890568,0.0008069272,0.0004506136,0.003940133,0.002107016,0.0001793889,0.0001925014,0.003265903],"genre_scores_gemma":[0.00001081034,0.991994,0.00007841885,0.0004662316,0.0008443564,0.003331009,0.0001243579,0.0001158849,0.003034928],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9707823,"threshold_uncertainty_score":0.9997402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025784617","doi":"10.1517/14728214.10.1.67","title":"The drug-based pipeline against restenosis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Restenosis; Medicine; Drug; Conventional PCI; Sirolimus; Paclitaxel; Percutaneous coronary intervention; Intensive care medicine; Stent; Internal medicine; Cardiology; Pharmacology; Myocardial infarction; Chemotherapy","authors":[{"name":"Pierre‐Frédéric Keller","is_ca":true},{"name":"Réda Ibrahim","is_ca":true},{"name":"Jean‐Claude Tardif","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05339832418767139,"gpt":0.3957091822183103,"spread":0.3423108580306389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004299492,0.0005756869,0.00115665,0.0003050676,0.0004269873,0.00006778207,0.0003732782,0.0002186262,0.0002510845],"category_scores_gemma":[0.0003568935,0.0003689277,0.00129247,0.0003871272,0.0001031864,0.00004171014,0.00009353918,0.0006370536,0.0004651555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003194888,"about_ca_system_score_gemma":0.0003550196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002720769,"about_ca_topic_score_gemma":0.000005813111,"domain_scores_codex":[0.9971154,0.0002085721,0.001052671,0.0005760421,0.0005758324,0.000471454],"domain_scores_gemma":[0.9970603,0.001073,0.0003835281,0.001121057,0.0001398143,0.0002223169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002406236,0.0002569064,0.000001023413,0.0007095402,0.00006591874,0.00001032898,0.00008892707,0.000009137542,4.578636e-8,0.0001567632,0.1823044,0.8163729],"study_design_scores_gemma":[0.000614737,0.0001190229,0.000002207199,0.0307442,0.00007967144,0.00001089384,0.0001604751,0.0003382228,0.000001666727,0.000002771804,0.9675685,0.0003576836],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001278225,0.984957,0.00006672409,0.006464638,0.002643503,0.0008864012,0.0000403571,0.0001731934,0.004766909],"genre_scores_gemma":[0.00002212372,0.990033,0.0002253126,0.001642931,0.002528051,0.0003592895,0.000718064,0.0001290673,0.004342172],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8160152,"threshold_uncertainty_score":0.9998763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411195516","doi":"10.1080/14728214.2025.2517582","title":"Motor fluctuations in Parkinson disease – a mini-review of emerging drugs","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre; Toronto Western Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Parkinson's disease; Disease; Physical medicine and rehabilitation; Neuroscience; Intensive care medicine; Internal medicine; Psychology","authors":[{"name":"Priti Gros","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03519880348203243,"gpt":0.3783357672910483,"spread":0.3431369638090159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024726,0.0006752564,0.002411054,0.0006775209,0.00009592946,0.00001178896,0.0002860886,0.0001958104,0.0004107685],"category_scores_gemma":[0.0004905442,0.0005152798,0.001041282,0.0009828453,0.00007015372,0.00006143299,0.000127531,0.000436828,0.00005808731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001581837,"about_ca_system_score_gemma":0.0004569413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004657131,"about_ca_topic_score_gemma":5.883292e-7,"domain_scores_codex":[0.9964634,0.0003092411,0.001283044,0.0008894628,0.0006099383,0.0004449488],"domain_scores_gemma":[0.9979732,0.0003884963,0.0004576094,0.0008313066,0.0000838077,0.0002655713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000733854,0.001017519,0.00002647637,0.06778634,0.0001711459,0.0000343305,0.0002489319,6.540749e-7,3.457585e-7,0.0002300532,0.01014551,0.9202653],"study_design_scores_gemma":[0.0007248894,0.0001440344,0.0000560649,0.1984865,0.0001735281,9.587769e-7,0.00004627838,0.00001771353,4.632273e-7,0.00005351486,0.8000185,0.0002775297],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001040901,0.9908852,0.000008413278,0.003193232,0.0008856005,0.002363838,0.0001035856,0.00008249583,0.002467225],"genre_scores_gemma":[0.00005670136,0.9938996,0.0001172707,0.003111477,0.0001656909,0.001049208,0.00072512,0.00006580026,0.0008091067],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9199878,"threshold_uncertainty_score":0.9997299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4414443225","doi":"10.1080/14728214.2025.2565189","title":"Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical trial; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunotherapy; Clinical neurology; Targeted therapy; Disease; MEDLINE","authors":[{"name":"Edgar Carnero Contentti","is_ca":false},{"name":"Vinícius Boldrini","is_ca":false},{"name":"Adriana Casallas‐Vanegas","is_ca":false},{"name":"Sanja Gluščević","is_ca":false},{"name":"Emine Rabia Koç","is_ca":false},{"name":"Sara Samadzadeh","is_ca":false},{"name":"Meral Seferoğlu","is_ca":false},{"name":"Natalia Szejko","is_ca":true},{"name":"Michael Levy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193818646769692,"gpt":0.4944612600731487,"spread":0.3750793953961795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001356742,0.000892199,0.003077403,0.0003614301,0.0006424608,0.00007651209,0.0005993348,0.0005519855,0.0001050948],"category_scores_gemma":[0.003024483,0.0005183549,0.002451247,0.000627432,0.0001644531,0.0000573634,0.0002860321,0.0009596763,0.00006665951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003743155,"about_ca_system_score_gemma":0.001163178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003175721,"about_ca_topic_score_gemma":0.000002974082,"domain_scores_codex":[0.9942701,0.000993643,0.001588748,0.001203827,0.001106112,0.0008375178],"domain_scores_gemma":[0.9952109,0.002302916,0.0006258945,0.001222843,0.0002407251,0.0003966527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008369821,0.0009302186,0.0000129689,0.003164274,0.002339109,0.000008242899,0.0001838208,4.130156e-7,2.841094e-7,0.00005851424,0.07365125,0.9112811],"study_design_scores_gemma":[0.02977147,0.0007452343,0.0000854817,0.0247601,0.0004450114,9.399048e-7,0.000150634,0.00007507533,9.993136e-7,0.000004085925,0.9435549,0.0004060654],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001894401,0.979951,0.00002449902,0.003484577,0.005519471,0.009840284,0.000433466,0.0001985305,0.0005292722],"genre_scores_gemma":[0.00002210279,0.9812874,0.0001271146,0.0003821566,0.008420593,0.004233332,0.003097315,0.0001223198,0.002307687],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.910875,"threshold_uncertainty_score":0.9997268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230999927","doi":"10.1517/eoed.8.2.297.21133","title":"Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Telithromycin; Ketolide; Streptococcus pneumoniae; Microbiology; Macrolide Antibiotics; Erythromycin; Efflux; Medicine; Antibiotics; Biology","authors":[{"name":"George G. Zhanel","is_ca":true},{"name":"Tamiko Hisanaga","is_ca":true},{"name":"Kim Nichol","is_ca":true},{"name":"Aleksandra Wierzbowski","is_ca":true},{"name":"Daryl J. Hoban","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05614382737932102,"gpt":0.3787878638256813,"spread":0.3226440364463603,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004132561,0.0005197095,0.000545727,0.0006791216,0.00107137,0.00007328388,0.0001043398,0.0002020161,0.0001085335],"category_scores_gemma":[0.0002317177,0.0004441589,0.0003975201,0.0004362397,0.00008469834,0.0002033112,0.00001622668,0.000272288,0.00006552255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006847074,"about_ca_system_score_gemma":0.0002875837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005946536,"about_ca_topic_score_gemma":0.00001484923,"domain_scores_codex":[0.9972082,0.0002451827,0.0006379908,0.0007971756,0.0004246883,0.0006867382],"domain_scores_gemma":[0.9982229,0.0002167312,0.0002033358,0.0007895027,0.0001589475,0.0004085877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001825013,0.01234137,0.01018574,0.0003340751,0.00133486,0.000141356,0.01852035,0.003658159,0.7236071,0.04183837,0.01435102,0.1718626],"study_design_scores_gemma":[0.003154777,0.004448195,0.0007247155,0.0003711756,0.00002970931,0.0000290323,0.001337031,0.0002051514,0.034463,0.0001313213,0.9545935,0.0005124382],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.958367,0.002476923,0.001252766,0.007296647,0.007510258,0.003053506,0.0000626048,0.001247088,0.01873315],"genre_scores_gemma":[0.9905676,0.000860594,0.0002393959,0.005223088,0.00146762,0.0008073751,0.00004880855,0.0001836541,0.0006019092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9402424,"threshold_uncertainty_score":0.999801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018561236","doi":"10.1517/14728214.9.1.191","title":"Superbugs & Superdrugs: A Focus on Antibacterials – 6th Annual SMi Conference","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Medicine; Cephalosporin; Antibiotics; Microbiology; Biology","authors":[{"name":"N H Georgopapadakou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03002027768341804,"gpt":0.3296238282892215,"spread":0.2996035506058035,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002748116,0.0003998298,0.0005986202,0.0004072572,0.0002310492,0.0000663645,0.0001696792,0.0001649774,0.001688791],"category_scores_gemma":[0.0001411901,0.000344945,0.0003242242,0.000383206,0.0001216082,0.0002039748,0.00005389385,0.0003052578,0.0009633609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001646725,"about_ca_system_score_gemma":0.0001610427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003391592,"about_ca_topic_score_gemma":0.00001118426,"domain_scores_codex":[0.9974666,0.0001033944,0.0005354873,0.0006740901,0.0007046899,0.0005157232],"domain_scores_gemma":[0.9986432,0.00006872314,0.0001124425,0.000629484,0.0001953999,0.0003507326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004286705,0.008769479,0.001284039,0.0003067562,0.001184871,0.0003084671,0.1195012,0.0007473851,0.5902327,0.0412132,0.1742252,0.05793988],"study_design_scores_gemma":[0.01428843,0.001670076,0.001984502,0.006975183,0.00004376128,0.0001118973,0.008019709,0.0001557209,0.1971345,0.0009233482,0.7668992,0.001793617],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9401798,0.0003883006,0.0009278706,0.04227176,0.000926278,0.0005452189,0.0001500538,0.000602298,0.01400837],"genre_scores_gemma":[0.9905449,0.000739951,0.0005325275,0.005504013,0.001054721,0.00004387348,0.0003321857,0.00005996304,0.001187908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.592674,"threshold_uncertainty_score":0.9999003,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}